Safety, tolerability, and pharmacokinetics of SMT C1100, a 2‐arylbenzoxazole utrophin modulator, following single‐ and multiple‐dose administration to healthy male adult volunteers

Benzer Materyaller

• Safety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, following Single- and Multiple-Dose Administration to Pediatric Patients with Duchenne Muscular Dystrophy
  Yazar:: Ricotti, Valeria, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Safety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, following Single- and Multiple-Dose Administration to Pediatric Patients with Duchenne Muscular Dystrophy.
  Yazar:: Valeria Ricotti, ve diğerleri
  Baskı/Yayın Bilgisi: (2016-01-01)
• Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteers
  Yazar:: Lee, Y, ve diğerleri
  Baskı/Yayın Bilgisi: (1999)
• Pharmacokinetic and pharmacodynamic profile following oral administration of the phosphodiesterase (PDE)4 inhibitor V11294A in healthy volunteers
  Yazar:: Gale, Donna Donigi, ve diğerleri
  Baskı/Yayın Bilgisi: (2002)
• Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers
  Yazar:: Orrell, Catherine, ve diğerleri
  Baskı/Yayın Bilgisi: (2008)